Liver biopsy for histological assessment: The case in favor
- PMID: 20339188
- PMCID: PMC3016505
- DOI: 10.4103/1319-3767.61245
Liver biopsy for histological assessment: The case in favor
Abstract
Liver biopsy (LB) is the gold standard method for assessment of liver histology. It provides valuable, otherwise unobtainable information, regarding the degree of fibrosis, parenchymal integrity, degree and pattern of inflammation, bile duct status and deposition of materials and minerals in the liver. This information provides immense help in the diagnosis and prognostication of a variety of liver diseases. With careful selection of patients, and performance of the procedure appropriately, the complications become exceptionally rare in current clinical practice. Furthermore, the limitations of sampling error and inter-/intra-observer variability may be avoided by obtaining adequate tissue specimen and having it reviewed by an experienced liver pathologist. Current noninvasive tools are unqualified to replace LB in clinical practice in the face of specific limitations for each tool, compounded by a poorer performance towards the assessment of the degree of liver fibrosis, particularly for intermediate stages.
Conflict of interest statement
Similar articles
-
Liver biopsy for histological assessment: The case against.Saudi J Gastroenterol. 2010 Apr-Jun;16(2):124-32. doi: 10.4103/1319-3767.61244. Saudi J Gastroenterol. 2010. PMID: 20339187 Free PMC article. Review.
-
A clinical and histopathologic perspective on evolving noninvasive and invasive alternatives for liver biopsy.Clin Gastroenterol Hepatol. 2008 May;6(5):491-6. doi: 10.1016/j.cgh.2008.02.023. Clin Gastroenterol Hepatol. 2008. PMID: 18455694
-
Liver biopsy in children: position paper of the ESPGHAN Hepatology Committee.J Pediatr Gastroenterol Nutr. 2015 Mar;60(3):408-20. doi: 10.1097/MPG.0000000000000632. J Pediatr Gastroenterol Nutr. 2015. PMID: 25383787 Review.
-
Diagnosis of liver fibrosis: present and future.Semin Liver Dis. 2015 May;35(2):166-83. doi: 10.1055/s-0035-1550059. Epub 2015 May 14. Semin Liver Dis. 2015. PMID: 25974902 Review.
-
Noninvasive assessment of liver fibrosis: serum markers, imaging, and other modalities.Clin Liver Dis. 2008 Nov;12(4):883-900, x. doi: 10.1016/j.cld.2008.07.010. Clin Liver Dis. 2008. PMID: 18984472 Review.
Cited by
-
Developmental origins of nonalcoholic fatty liver disease as a risk factor for exaggerated metabolic and cardiovascular-renal disease.Am J Physiol Endocrinol Metab. 2018 Nov 1;315(5):E795-E814. doi: 10.1152/ajpendo.00394.2017. Epub 2018 Mar 6. Am J Physiol Endocrinol Metab. 2018. PMID: 29509436 Free PMC article. Review.
-
Breaking new ground: first report of integrating clinical, hematobiochemical, sonographic, and pathological findings in dromedary camels (Camelus dromedarius) with hepatic fibrosis.Front Vet Sci. 2025 Jul 9;12:1639628. doi: 10.3389/fvets.2025.1639628. eCollection 2025. Front Vet Sci. 2025. PMID: 40703928 Free PMC article.
-
Transient Elastography for Assessment of Liver Fibrosis and Steatosis: An Evidence-Based Analysis.Ont Health Technol Assess Ser. 2015 Nov 1;15(18):1-45. eCollection 2015. Ont Health Technol Assess Ser. 2015. PMID: 26664664 Free PMC article. Review.
-
Quantitative assessment of liver fibrosis by digital image analysis reveals correlation with qualitative clinical fibrosis staging in liver transplant patients.PLoS One. 2020 Sep 28;15(9):e0239624. doi: 10.1371/journal.pone.0239624. eCollection 2020. PLoS One. 2020. PMID: 32986732 Free PMC article.
References
-
- Schiff ER, Sorrell MF, Willis C. Schiff's Diseases of the Liver textbook. Lippincott Williams and Wilkins; 2003. p. 257.
-
- Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD. Liver biopsy. Hepatology. 2009;49:1017–44. - PubMed
-
- Czaja AJ, Carpenter HA. Optimizing diagnosis from the medical liver biopsy. Clin Gastroenterol Hepatol. 2007;5:898–907. - PubMed
-
- Chazouillères O, Wendum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: Clinical features and response to therapy. Hepatology. 1998;28:296–301. - PubMed
-
- Powell EE, Jonsson JR, Clouston AD. Steatosis: Co-factor in other liver diseases. Hepatology. 2005;42:5–13. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical